 |
|
CLINICIAN'S CORNER
Does This Patient Have a Family History of Cancer?
An Evidence-Based Analysis of the Accuracy of Family Cancer History
Harvey J. Murff, MD, MPH;
David R. Spigel, MD;
Sapna Syngal, MD, MPH
JAMA. 2004;292:1480-1489.
Context A family history of certain cancers is associated with an increased risk of developing cancer. Both cancer screening and genetic services referral decisions are often based on self-reported pedigree information.
Objective To determine the accuracy of self-reported family cancer history information.
Data Sources English-language articles were retrieved by searching MEDLINE (1966-June 2004) using Medical Subject Headings family, genetic predisposition to disease, medical history taking, neoplasm, and reproducibility of results. Additional articles were identified through bibliography searches.
Study Selection Original studies in which investigators validated self-reported family history by reviewing the identified relatives' medical records, death certificate, or cancer registry information were included, as well as studies that evaluated breast, colon, ovarian, endometrial, and prostate cancers.
Data Extraction Two of the 3 investigators independently reviewed and abstracted data for estimating the likelihood ratios (LRs) of self-reported family cancer history information. Only data from studies that evaluated both positive and negative family cancer histories were included within the analyses. A total of 14 studies met the search criteria and were included in the review.
Data Synthesis For patients without a personal history of cancer, the positive and negative LRs of a family history of the following cancers in a first-degree relative were 23.0 (95% confidence interval [CI], 6.4-81.0) and 0.25 (95% CI, 0.10-0.63) for colon cancer; 8.9 (95% CI, 5.4-15.0) and 0.20 (95% CI, 0.08-0.49) for breast cancer; 14.0 (95% CI, 2.2-83.4) and 0.68 (95% CI, 0.31-1.52) for endometrial cancer; 34.0 (95% CI, 5.7-202.0) and 0.51 (95% CI, 0.13-2.10) for ovarian cancer; and 12.3 (95% CI, 6.5-24.0) and 0.32 (95% CI, 0.18-0.55) for prostate cancer, respectively. Positive predictive values tended to be better in articles concerning first-degree relatives compared with second-degree relatives.
Conclusions Patient-reported family cancer histories for first-degree relatives are accurate and valuable for breast and colon cancer risk assessments. Negative family history reports for ovarian and endometrial cancers are less useful, although the prevalence of these malignancies within families is low.
Author Affiliations: Division of General Internal Medicine, Vanderbilt University Medical Center, and Department of Veterans Affairs, Tennessee Valley Healthcare System (Dr Murff), and the Sarah Cannon Cancer Center (Dr Spigel), Nashville, Tenn; Division of Gastroenterology, Brigham and Women's Hospital and Population Sciences Division, Dana-Farber Cancer Institute, Boston, Mass (Dr Syngal).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalisations in Sweden
Hemminki et al.
J. Epidemiol. Community Health 2008;62:398-401.
ABSTRACT
| FULL TEXT
Colonoscopy Screening in African Americans and Whites With Affected First-Degree Relatives
Murff et al.
Arch Intern Med 2008;168:625-631.
ABSTRACT
| FULL TEXT
Multiple Diagnostic X-rays for Spine Deformities and Risk of Breast Cancer
Ronckers et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:605-613.
ABSTRACT
| FULL TEXT
Familial Risks for Cancer as the Basis for Evidence-Based Clinical Referral and Counseling
Hemminki et al.
The Oncologist 2008;13:239-247.
ABSTRACT
| FULL TEXT
Estimating risks of common complex diseases: familial and population risks
Hemminki et al.
J. Med. Genet. 2008;45:126-127.
FULL TEXT
How common is familial cancer?
Hemminki et al.
Ann Oncol 2008;19:163-167.
ABSTRACT
| FULL TEXT
Family History in Pediatric Primary Care
Trotter and Martin
Pediatrics 2007;120:S60-S65.
ABSTRACT
| FULL TEXT
Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk?
Murta-Nascimento et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1595-1600.
ABSTRACT
| FULL TEXT
Breast Cancer in First-degree Relatives and Risk of Lung Cancer: Assessment of the Existence of Gene-Sex Interactions
Tsuchiya et al.
Jpn J Clin Oncol 2007;0:hym048v1-5.
ABSTRACT
| FULL TEXT
Racial Differences in Cancer Risk Among Relatives of Patients With Early Onset Lung Cancer
Naff et al.
Chest 2007;131:1289-1294.
ABSTRACT
| FULL TEXT
Non-Hodgkin's Lymphoma and Family History of Hematologic Malignancy
Mensah et al.
Am J Epidemiol 2007;165:126-133.
ABSTRACT
| FULL TEXT
Familial risks for nerve, nerve root and plexus disorders in siblings based on hospitalisations in Sweden
Hemminki et al.
J. Epidemiol. Community Health 2007;61:80-84.
ABSTRACT
| FULL TEXT
Family History of Cancer and the Risk of Renal Cell Cancer
Negri et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2441-2444.
ABSTRACT
| FULL TEXT
Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
Balmana et al.
JAMA 2006;296:1469-1478.
ABSTRACT
| FULL TEXT
Family History of Hemolymphopoietic and Other Cancers and Risk of Non-Hodgkin's Lymphoma.
Negri et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:245-250.
ABSTRACT
| FULL TEXT
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force
Nelson et al.
ANN INTERN MED 2005;143:362-379.
ABSTRACT
| FULL TEXT
Spectral Markers in Preneoplastic Intestinal Mucosa: An Accurate Predictor of Tumor Risk in the MIN Mouse
Roy et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1639-1645.
ABSTRACT
| FULL TEXT
Risk of Lung Cancer Among White and Black Relatives of Individuals With Early-Onset Lung Cancer
Cote et al.
JAMA 2005;293:3036-3042.
ABSTRACT
| FULL TEXT
Alteration of Gene Expression in Macroscopically Normal Colonic Mucosa from Individuals with a Family History of Sporadic Colon Cancer
Hao et al.
Clin. Cancer Res. 2005;11:1400-1407.
ABSTRACT
| FULL TEXT
|
